Rob Bresnahan Stock Trades — 600+ Disclosures, Controversy & the TRUST Act

Rob Bresnahan Jr. (born April 22, 1990) grew up in Wyoming Borough and Hughestown, Pennsylvania. He graduated from Wyoming Seminary in 2008 and earned a B.S. in Business Administration from the University of Scranton in 2012. After college he became CEO of Kuharchik Construction, the family business, growing it to over 150 employees with a focus on power distribution and intelligent transportation systems. He also founded The Landmark in Pittston, a real estate development group. His community board service includes Junior Achievement, the Wilkes-Barre Catholic Youth Center, and the Luzerne County SPCA. Bresnahan flipped Pennsylvania's 8th District in the 2024 election, taking the seat vacated by Democrat Matt Cartwright. He was sworn in January 3, 2025. His committee assignments place him at the intersection of infrastructure and regional economic development: Transportation and Infrastructure (Vice Chair of the Highways and Transit Subcommittee), Agriculture, and Small Business. This matters for his trading record because several of his disclosed stock transactions involve companies under committee jurisdiction — Caterpillar (CAT), CSX (CSX), and Boeing (BA) all fall under Transportation and Infrastructure oversight. He belongs to the Main Street Caucus, Problem Solvers Caucus, and Republican Governance Group. Quiver Quantitative estimates his net worth at roughly $36.4 million with approximately $12.2 million to $13.9 million in publicly traded securities.

The most scrutinized sequence in Bresnahan's trading record involves Centene Corporation (CNC), a major Medicaid managed-care provider. On April 8, 2025, his financial advisor purchased Centene shares in the $1,001 to $15,000 range. That same day, his account also held positions in Elevance Health (ELV), UnitedHealth Group (UNH), and CVS Health (CVS). On May 15, 2025, he sold Centene and the other three healthcare stocks — a combined sell-off totaling up to $130,000, per NBC News reporting in November 2025. One week later, on May 22, he voted yes on the House budget reconciliation bill that included roughly $1 trillion in Medicaid cuts over ten years. Centene shares dropped 35-40% after the bill became law in July 2025. I ran the calendar math on this myself: Bresnahan held Centene for 37 days, from purchase to sale. The sale landed seven days before his vote. His office maintains he had no knowledge of the trades, as a financial advisor manages the portfolio without his input. The timing similarity between the sell-off and the legislative calendar has generated a stream of ethics questions, though no formal investigation has been launched as of mid-2026.